References
- Kluge S, Braune SA, Engel M, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med. 2012;38(10):1632-1639. doi:10.1007/s00134-012-2649-2
- Abrams D, Combes A, Brodie D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol. 2014;63(25 pt A):2769-2778. doi:10.1016/j.jacc.2014.03.046
- MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 2012;38(2):210-220. doi:10.1007/s00134-011-2439-2
- Shin TG, Choi JH, Jo IJ, et al. Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation. Crit Care Med. 2011;39(1):1-7. doi:10.1097/CCM.0b013e3181feb339
- Alsoufi B, Al-Radi OO, Nazer RI, et al. Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest. J Thorac Cardiovasc Surg. 2007;134(4):952-959.e2. doi:10.1016/j.jtcvs.2007.05.054
- Khorsandi M, Dougherty S, Bouamra O, et al. Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Surg. 2017;12(1):55. doi:10.1186/s13019-017-0618-0
- Arlt M, Philipp A, Voelkel S, et al. Extracorporeal membrane oxygenation in severe trauma patients with bleeding shock. Resuscitation. 2010;81(7):804-809. doi:10.1016/j.resuscitation.2010.02.020
- Hughes R, Cipolla J, Thomas PG, Stawicki SP. Extracorporeal membrane oxygenation in traumatic injury: an overview of utility and indications. In: Firstenberg MS, ed. Extracorporeal Membrane Oxygenation – Advances in Therapy. IntechOpen Limited; 2016:chap 11. doi:10.5772/63434
INDICATIONS FOR USE
The Novalung System is indicated for long-term (>6 hours) respiratory/cardiopulmonary support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 removal) of the patient's blood in adults with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent. These may include:
- Failure to wean from cardiopulmonary bypass following cardiac surgery in adult patients
- ECMO-assisted cardiopulmonary resuscitation in adults
Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. The Indications for Use for this device can be found at https://fmcna.com/products/indications-safety-and-warnings.
© 2024 Â鶹Éçmadou Medical Care. All Rights Reserved. Â鶹Éçmadou Medical Care, the triangle logo, Novalung, X-Lung, and x.ellence are trademarks of Â鶹Éçmadou Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. 105688-03 Rev A 02/2024
Ìý